Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants

Por Buitelaar, Jan, Medori, Rossella
Publicado em 2009

Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening

Por Phillips, Glenn A, Wyrwich, Kathleen W, Guo, Shien, Medori, Rossella, Altincatal, Arman, Wagner, Linda, Elkins, Jacob
Publicado no Mult Scler (2014)

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Por Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob
Publicado no Mult Scler (2016)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

Por Buitelaar, Jan K, Ramos-Quiroga, J Antoni, Casas, Miguel, Kooij, J J Sandra, Niemelä, Asko, Konofal, Eric, Dejonckheere, Joachim, Challis, Bradford H, Medori, Rossella
Publicado em 2009